![RTM added as distributor NeuraCeq®](https://radboudtranslationalmedicine.nl/cdn/c23b15a6-eef5-4843-a143-f51c61ba0b6a/-/smart_resize/250x170/-/format/auto/-/quality/smart/neuraceq.png)
RTM added as distributor NeuraCeq®
Exciting news! Life Molecular Imaging’s NeuraCeq® 300 MBq/ml solution for injection (florbetaben 18F...
![First Patient Dosed with TLX250-CDx in Italy for ccRCC](https://radboudtranslationalmedicine.nl/cdn/45d80979-3021-4c1a-aec1-225f1cfcea01/-/smart_resize/250x170/-/format/auto/-/quality/smart/telix-first-patient-dose-italy.png)
First Patient Dosed with TLX250-CDx in Italy for ccRCC
The below product is manufactured at RTM First Patient dosed with TLX250-CDx in Italy for ccRCC Th...
![LinkedIn post ESRR2024](https://radboudtranslationalmedicine.nl/cdn/7049c8c5-f203-4958-9f1d-f645eecae7d2/-/smart_resize/250x170/-/format/auto/-/quality/smart/1706255446607.jpeg)
LinkedIn post ESRR2024
📢 Important update on EU #GMP Annex 1 at #ESRR2024! The revised EU GMP Annex 1, effecti...
ABX has received marketing authorisation for the radiotracer Radelumin® in Germany
ABX has received marketing authorisation for the radiotracer Radelumin® in Germany! This marks the 8...
![First Patient Dosed in Phase II Study of TLX250-CDx in Triple-Negative Breast Cancer](https://radboudtranslationalmedicine.nl/cdn/6bac4557-a1f4-4d63-9b07-9644f2141bfa/-/smart_resize/250x170/-/format/auto/-/quality/smart/telix-nieuwsbericht.jpg)
First Patient Dosed in Phase II Study of TLX250-CDx in Triple-Negative Breast Cancer
The below product is manufactured at RTM First Patient Dosed in Phase II Study of TLX250-CDx in Tri...
![Huntington’s Disease: A Review of the Known PET Imaging Biomarkers and Targeting Radiotracers](https://radboudtranslationalmedicine.nl/cdn/3b3bec47-866e-401d-a8d4-0344b20a02a3/-/smart_resize/250x170/-/format/auto/-/quality/smart/page-1-article-kc.jpg)
Huntington’s Disease: A Review of the Known PET Imaging Biomarkers and Targeting Radiotracers
Klaudia Cybulska (postdoc radiochemistry) has written an article about Huntington's Disease. Abstra...
![Cooperation RTM-Alliance Medical](https://radboudtranslationalmedicine.nl/cdn/291b0954-582f-4b77-b3c0-de9b91f28f6a/-/smart_resize/250x170/-/format/auto/-/quality/smart/029radboud-ossip.jpg)
Cooperation RTM-Alliance Medical
It is with great pleasure that we announce our cooperation with Alliance Medical Group (AMG) regardi...
![RTM receives marketing authorisation for Fludeoxyglucose (18F)](https://radboudtranslationalmedicine.nl/cdn/b4cab29f-4a7a-4a09-a1d0-568d3e3446ea/-/smart_resize/250x170/-/format/auto/-/quality/smart/plc04276-hr.jpg)
RTM receives marketing authorisation for Fludeoxyglucose (18F)
We are happy to announce that RTM has received marketing authorization for 18F-FDG of 17 July 2018....
![1st production QuiremSpheres](https://radboudtranslationalmedicine.nl/cdn/7bc02248-6fd7-49f7-9804-02f59c60fcef/-/smart_resize/250x170/-/format/auto/-/quality/smart/transport.jpg)
1st production QuiremSpheres
On May 21st, the first patient dosis of QuiremSpheres was processed at RTM and then shipped to the s...
![Production of novel diagnostic radionuclides in small medical cyclotrons](https://radboudtranslationalmedicine.nl/cdn/25b47553-0ca5-49e8-a955-014516c0947d/-/smart_resize/250x170/-/format/auto/-/quality/smart/026radboud-ossip.jpg)
Production of novel diagnostic radionuclides in small medical cyclotrons
Employees from RTM and Radboudumc have published a new article: 'Production of novel diagnostic radi...
![First liver cancer patient treated with microspheres irradiated in TU Delft](https://radboudtranslationalmedicine.nl/cdn/3a49d092-734f-432a-99c4-00e35f2319bc/-/smart_resize/250x170/-/format/auto/-/quality/smart/infographic-eng-nieuwe20bestralingsfaciliteit20tu20delft-600pix-def.jpg)
First liver cancer patient treated with microspheres irradiated in TU Delft
Radboud Translational Medicine will perform the dispensing of below product. The production and dis...
![18F-FDOPA now available](https://radboudtranslationalmedicine.nl/cdn/dde0a2a7-a571-4ff2-924d-3fd7f3a0878f/-/smart_resize/250x170/-/format/auto/-/quality/smart/041radboud-ossip.jpg)
18F-FDOPA now available
Fluorodopa (18F) is now available for clinical studies and - with doctor's certificate - for routine...
![GMP-certificate received](https://radboudtranslationalmedicine.nl/cdn/d8e82eeb-ebb5-4876-a874-f2bd22bd1425/-/crop/433x294/7,-14/-/smart_resize/250x170/-/scale_crop/250x170/smart/-/format/auto/-/quality/smart/logo-igz.png)
GMP-certificate received
Today we received our GMP-certificate!The results of the inspection were excellent and no shortcomin...
![Upcoming event](https://radboudtranslationalmedicine.nl/cdn/72adb851-49a0-43fb-8ffa-b95d16cae731/-/smart_resize/250x170/-/format/auto/-/quality/smart/eanm2016-360x203.jpg)
Upcoming event
From October 15 to October 19, Radboud translational medicine will attend the 29th annual congress o...
Interested in our products?
Contact us to discuss the possibilities.